These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25372468)

  • 1. An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.
    Ni XJ; Zhang XL; Ou-Yang QW; Qian GW; Wang L; Chen S; Jiang YZ; Zuo WJ; Wu J; Hu X; Shao ZM
    PLoS One; 2014; 9(11):e111886. PubMed ID: 25372468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy.
    Marín Hernández C; Piñero Madrona A; Gil Vázquez PJ; Galindo Fernández PJ; Ruiz Merino G; Alonso Romero JL; Parrilla Paricio P
    Clin Transl Oncol; 2018 Apr; 20(4):476-483. PubMed ID: 28785911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
    Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
    PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
    Goto W; Kashiwagi S; Asano Y; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Nov; 18(1):1137. PubMed ID: 30453914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.
    Peng Y; Chen R; Qu F; Ye Y; Fu Y; Tang Z; Wang Y; Zong B; Yu H; Luo F; Liu S
    Cancer Biol Ther; 2020; 21(2):189-196. PubMed ID: 31684807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision.
    Xiao WW; Zhang LN; You KY; Huang R; Yu X; Ding PR; Gao YH
    J Cancer; 2015; 6(7):616-22. PubMed ID: 26078791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
    Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
    Jiang R; Cai XY; Yang ZH; Yan Y; Zou X; Guo L; Sun R; Luo DH; Chen QY; Huang PY; Xiang YQ; Lu X; Wang L; Xia WX; Mai HQ; Chen MY
    Chin J Cancer; 2015 Jun; 34(6):237-46. PubMed ID: 26067059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study.
    Wen J; Ye F; Huang X; Li S; Yang L; Xiao X; Xie X
    Medicine (Baltimore); 2015 Dec; 94(49):e2266. PubMed ID: 26656374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients with resected breast cancer.
    Deng Y; Li W; Liu X; Ma G; Wu Q; Chen F; Wang Z; Zhou Q
    Medicine (Baltimore); 2020 May; 99(18):e18755. PubMed ID: 32358341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of the postoperative lymphocyte-to-monocyte and monocyte-to-red blood cell ratio in predicting locoregional and distant metastases after breast cancer resection - Retrospective study.
    Grupińska J; Budzyń M; Janowski J; Brzeziński J; Gryszczyńska B; Leporowska E; Formanowicz D; Kycler W
    Adv Med Sci; 2024 Mar; 69(1):103-112. PubMed ID: 38394965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
    He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
    Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients.
    Losada B; Guerra JA; Malón D; Jara C; Rodriguez L; Del Barco S
    Clin Transl Oncol; 2019 Jul; 21(7):855-863. PubMed ID: 30506134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer.
    Meng X; Wang X; Jiang C; Zhang S; Cheng S
    Transl Oncol; 2022 Apr; 18():101355. PubMed ID: 35121221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Lin GN; Liu PP; Liu DY; Peng JW; Xiao JJ; Xia ZJ
    Chin J Cancer; 2016 Jan; 35():5. PubMed ID: 26740116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.